Context: Known polymorphisms of DNA repair genes can be associated with the risk of many types of cancer. There is no consensus regarding association between XRCC1 and OGG1 with breast cancer (BC). Objectives: The aim of this study is to collect relevant published studies systematically. Data Sources: Sixty-two publications were identified through searching PubMed, PubMed Central, ISI web of knowledge, and reference list of related articles. Study Selection: We performed a systematic review according MOOSE guideline criteria. All longitudinal cohort and case-control studies investigating association of any type and grade of breast cancer with XRCC1 and OGG1 gene and their polymorphisms were eligible for initial inclusion. Data Extraction: Two authors screened titles and abstracts and extracted all needed information from eligible studies. Four research methodological components causing bias for the association between gene polymorphisms and breast cancer risk, including source of controls sampling, population ethnicity, sample size of studies and menopausal status of cases and controls was used for assessment of quality of studies Results: A total of 14,793 breast cancer cases and 15,409 controls were included in assessment of XRCC1 Arg194Trp. Four studies showed significant association and one study showed protective effect of XRCC1 Arg194Trp and BC. A total of 7,716 cases and 7,370 controls were included for XRCC1 Arg280His. Only one study showed significant association of XRCC1 Arg280His and breast cancer (OR = 1.82 (1.06 -3.15). A total of 27,167 cases and 31,998 controls were included to estimate association between XRCC1 Arg399Gln polymorphism and breast cancer. Seven studies showed significant association and one showed protective effect of XRCC1 Arg399Gln and BC. A total of 9,417 cases and 11,087 controls were included for OGG1 Ser326Cys. Among studies focused on OGG1 Ser326Cys, none showed significant association with breast cancer. Conclusions: Systematic search of major databases identify many studies addressing the relationship between BC and susceptible alleles in the base excision repair genes and the fact that there are many variations in the magnitude of association depending on inheritance model and the population of the study. 
Context
Breast cancer (BC) counts the most common cause of cancer related death among women. The studies reported about 235303 new cases of BC and about 40430 death records per year in the United States (1) . BC is the result of collaboration of many variables including environmental, reproductive, lifestyle, and genetic related factors (2) and approximately 10% of BC cases are attributed to genetic factors (3) .
Mutations in high-penetrance genes such as BRCA1, BRCA2, TP53 and PTEN are demonstrated to contribute in BC susceptibility (4) . However, they are counted only for 25% of inherited BC risk (5) . A combined polymorphism effect of moderate and common low risk genes can clear remaining hereditary BC risk (6) . Base-excision repair (BER) genes are an important subcategory of DNA repair genes, which fix DNA base damage due to X-rays, oxygen radicals, and alkylating agents (7) . BER pathway excise oxidized DNA bases when oxidized DNA damage occur (8) . Mutations in BER genes by cumulative effect of endogenous and exogenous mutagens result in apoptosis or cell overgrowth and cancer. Known polymorphisms of DNA repair genes can be associated with the risk of many types of cancer such as lung (9) , colorectal (10), bladder (11) , and BC (12) . On the other hand, there are evidences demonstrating no association or protective effect of BER genes with breast cancer (11, 13, 14) .
X-ray repair cross-complementing group 1 gene (XRCC1) and 8-oxoguanine DNA glycosylase (OGG1) play an impor-tant role in base-excision repair pathway. XRCC1 acts in BER encoding scaffolding protein that assemble together proteins of the DNA repair complex (15, 16) . Arg194Trp, Arg280His and Arg399Gln amino acid substitution are the most common studied single nucleotide polymorphisms of XRCC1. OGG1 encodes a DNA glycosylase, an important enzyme in the repair of 8-oxoguanine (17) . Amino acid replacement of serine (Ser) with cysteine (Cys) at codon 326 (Ser326Cys, rs1052133) as a result of common C/G single nucleotide polymorphism (SNP) in exon 7 of hOGG1 gene is associated with decreased hOGG1 repair activity (18) .
There are studies recommending variation in association of genetic polymorphisms and diseases in different ethnicities and geographical populations (19, 20) . There is no consensus among researchers regarding association between XRCC1 (21-24) and OGG1 (12, 25, 26) with BC. A case-control study in the United States and Poland populations which evaluated association of BER genes with BC (27) showed no association for XRCC1 and OGG1 in both populations. While other studies (28) (29) suggested association of XRCC1 (codon 194, codon 280, and codon 399) and OGG1 (codon 326) with breast cancer.
Objectives
As such, we aimed to conduct a comprehensive systematic review to address the association of XRCC1 and OGG1 polymorphisms with breast cancer.
Data Sources
The systematic review was conducted according to the meta-analysis of observational studies in epidemiology (MOOSE) group's criteria (30) . To extract all studies around genetic polymorphisms and breast cancer, we performed a sensitive search in PubMed, PubMed central and ISI web of knowledge from their commencements until September 2014. The search was carried out using keywords "Breast Neoplasms", "Breast Tumor", "Human Mammarygating association of breast cancer with XRCC1 and OGG1 genes and their polymorphisms were eligible for initial inclusion. Also, all types (carcinomas, sarcomas) and grades (low, intermediate/moderate and high grade) of breast cancer were considered in this review. The criteria for exclusion of articles on the basis of title and abstract screening were: 1) Studies with no control group, 2) non-research articles (all type of letters, comments, and editorial), 3) animal studies, 4) case reports and case series studies, 5) considered occurrence of secondary/metastatic breast cancer or all-cause mortality as an outcome , 6) considered patients undergoing any type of intervention and 7) studies without breast cancer (pre/post-menopausal) as outcome. If the same population had been studied in two or more different studies (articles), we chose the most comprehensive and the most recent one.
Data Extraction
Two authors screened titles and abstracts and extracted all needed information from eligible studies after exclusion of duplicate titles. If there was a disagreement in each stage, three authors discussed conflicting results. EndNote X7 software was used to manage review and organize screening.
The following data were extracted from each study: name of first authors, date of publication, study design, source of controls, considered confounders in each models, genotyping methods, population ethnicity, total number of cases and controls, menopausal status of cases and controls, number of cases and controls according to genotypes and menopausal status, mean age of cases and controls, frequency of each genotypes separately and odds ratios for homozygote, heterozygote and combined model.
Because of the potential hazards of assessing the quality of studies using mechanical checklist and scoring the preconsidered item which is not made specifically for genetic epidemiology researches (31) (32) (33) (34) . For quality assessment procedure, we used four research methodological components causing bias for the association between gene polymorphisms and breast cancer risk, including source of controls sampling, population ethnicity, sample size of studies and menopausal status of cases and controls (Appendix 2 to 5). In order to minimize potential errors, considered data extracted on a former piloted Microsoft Excel worksheet, accompanied by predefined instructions for reviewers. In final stage, senior researcher re-checked extracted data. If clarifications and more information (or unavailable full texts) were needed, we contacted the first and corresponding author for additional data.
Results

Eligible Studies
A total of 2424 titles were identified in initial electronic search. After final screening, 45 eligible publications (in-cluding 49 studies) through primary search, 13 publications (14 studies) through hand search of references list of retrieved citations and 6 through an update search of databases were retrieved ( Figure 1 ). Two studies (35, 36) were excluded because of having overlapping population with two others (37, 38) . Overall, 62 publications (67 studies) were included in this study according to inclusion and exclusion criteria (12, (21) (22) (23) (25) (26) (27) (28) (29) . General characteristics of all eligible studies separated for each gene are provided in Appendix 6 to 9. Different ethnicities populations in the same study were considered as separated study populations (five publications comprised of two populations with different ethnicities) (27, 43, 47, 68, 83 (46, 52, 56, 74, 87) , four studies because of stratification were based on family history of breast cancer (22, 44, 48, 86) and one because of stratification was based on recreational activity (63) . 
Arg280His
A total of 7,716 cases and 7,370 controls were studied for Arg280His. Zhang's study (27) had the largest sample size (n = 2,802) and Smith's study (83) (this study consists of two different ethnic populations and here the African American population was studied) had the lowest (n = 128). Histidine (His) allele had the least frequency among studies population comparing to other three alleles. His allele frequency ranged from 0.03 to 0.11 in cases and from 0.03 to 0.14 in controls. Six of studies (4 publications) were conducted in the United States of America (27, 68, 83, 89) . Seven studies (six publications) had a clinic-based design and five (four publications) had a population-based design. Genotyping of four studies (28, 59, 60, 64) was carried out by PCR-RFLP (Appendix 7).
Results of Arg280His showed significant association between Arg280His polymorphism and breast cancer comparing His carriers versus wild type only in one study (67) with OR = 1.82 (1.06 -3.15). ORs ranged from NC to 1.69 (adjusted) and NC to 4.68 (unadjusted) for homozygote versus wild type, from 0.55 to 1.80 (adjusted) and 0.56 to 1.13 (unadjusted) for heterozygote versus wild type and from 0.61 to 1.3 (adjusted) and 0.63 to 1.82 (unadjusted) for His carriers versus wild type. Stratification for menopausal status revealed marginally significant association in one study (29) (OR = 1.71 (0.94 -3.10); P = 0.07) and protective association of Arg280His polymorphism in another study (28) (OR = 0.26 (0.1 -0.66)) for post-menopausal women ( Table 2 ). 
Arg399Gln
Arg399Gln was the most popularly evaluated polymorphism and 27167 cases and 31998 controls were studied to estimate association between Arg399Gln polymorphism and breast cancer. The sample sizes ranged from 74 to 7,25 individuals in which the largest and smallest studies were carried out by Sapkota (79) and Sterpone (38) , respectively. Glutamine (Gln) allele frequency ranged from 0.14 to 0.55 in cases and 0.11 to 0.57 in controls. 19 of 56 studies (16 publications) were conducted in the United States of America. Thirty-one studies used PCR-RFLP method for genotyping and thirty-three studies had clinic based study design (Appendix 8). Among studies analyzing Arg399Gln, seven (28, 38, 47, 61, 71, 80, 86) showed significant association between Arg399Gln polymorphism and breast cancer comparing Gln carriers versus wild type. Although six studies (27, 29, 53, 62, 64, 66) showed a borderline association, just one (64) (28) and three for postmenopausal woman (61, 72, 74) . Nonetheless, one study showed protective effect of Arg399Gln polymorphism for breast cancer risk (57) . Details of extracted ORs are reported in Table 3 .
Ser326Cys
A total of 9,417 cases and 11,087 controls were founded to be considered for Ser326Cys. Respectively, Roberts' study (72) and Sterpone's (38) study had the largest and smallest sample sizes of 2,941 and 74 individuals. Cysteine (Cys) allele was the most prevalent allele in this study and Cys frequency ranged from 0.21 to 0.63 in cases and 0.21 and 0.68 in controls. About half of studies of Ser326Cys polymorphism were conducted in Asia, particularly on Chinese populations. Design of 13 studies (12 publications) was clinic based (Appendix 9). Among studies focusing on Ser326Cys, none showed significant association between Ser326Cys polymorphism and breast cancer comparing Cys carriers to wild type. Calculated ORs ranged from 0.69 to 1.70 (adjusted) and 0.22 to 1.46 (unadjusted) for homozygote versus wild type, from 0.82 to 1.20 (adjusted) and 0.33 to 1.37 (unadjusted) for heterozygote versus wild type and from 0.76 to 1.21 (adjusted) and 0.28 to 1.28 (unadjusted) for Cys carriers versus wild type. Stratification for menopausal status exhibited no significant association between Ser326Cys and breast cancer in pre and post-menopausal women, but Romanowicz-Makowska (75) showed protective effect in post-menopausal women (OR = 0.49 (0.24 -0.98)) ( Table 4) .
As part of a systematic review to address variations seen in the association between polymorphic genes involved in base excision repair pathway and risk of breast cancer, we identified all studies indexed in PubMed and Web of Sciences in which the risk of barest cancer for carriers of susceptibility alleles of XRCC1 and OGG1 genes were investigated. Collectively, there were 62 studies assessing the BER gene polymorphism in different population providing a wealth of information to look at the cause of variation in allele frequency as well as the magnitude of association between this polymorphic genes and breast cancer.
Etiology of breast cancer is characterized with major influence of endogenic estrogen exposure and gens involved in cancer susceptibility or genes involved in different pathways of estrogen metabolism (90) . The lifestyle and environmental factors play important role in modifying the magnitude of estrogen exposure in a background of several susceptibility genes (91) . The highly penetrate genes of BRCA1 and BRCA2 accounts for up to 25% of inherited breast cancer (where not more than 10% of breast cancer are considered as familial and inherited) (92, 93) . The involvement of low-penetrate susceptibility polymorphic genes involved in the pathophysiologic pathways of breast tumor genesis play major role in sporadic breast cancer (94) . The polymorphic genes can be involved in several cellular mechanisms especially estrogen metabolism pathways, detoxification of xenobiotic, cell adhesion, and DNA damage and repair signaling. While polymorphic genes involved in estrogen metabolism are very specific to breast cancer susceptibility, polymorphic genes involved in DNA repair and damage play an important role in the etiology of many cancers including breast (95) . Among the many polymorphic genes involved in the etiology of breast cancer, Base excision repair polymorphic genes shows especially important role as a mechanism involved in repairing endogenous driven DNA damage, which may originate from wide range of normal metabolism. The magnitude of association (expressed as odds ratio in case-control and rate ration in cohort studies) between low penetrance genes and risk of cancer is very small and barely ranges more than 1.5. From population standpoint, the small magnitude of association seen between the susceptibility allele and risk of cancer is aggregated into an important causal factor in the light of high prevalence of susceptibility allele. As the systematic review result, the prevalence of susceptibility allele in controls group for XCCR1 Arg194Trp ranged from 2% in populations of Finland (50) and Saudi Arabia (39) to 57% in the population of Poland (37) . For XRCC1 Arg280His the prevalence ranged between 3% in African-American population of USA (68) to 14% in population of India (28) . For XRCC1 Arg399Gln, the prevalence ranged between 11% for African-American population of the US (83) to 57% for the population of Poland (37) . For OGG1 Ser326Cys, the prevalence ranged between 21% for populations of Spain (73) and USA (27) to 68% for the population of Poland (87) . www.ijcancerprevention.com The distribution of a susceptibility allele in a population is supposed to follow the Hardy-Weinberg law, unless a known population stratification or funder effect disturbs the HWE law (96) . In studies of association between a susceptible allele and risk of cancer when there is no indication of population stratification or funder effect, the differential frequency of the susceptibility allele among the diseased compared to non-diseased provides the bases for association studies. Lack of HWE law in distribution of susceptible allele confounds any study assessing association between susceptibility allele and cancer risk (97, 98) . In our systematic review, it was observed that HWE law was assessed for all the studies. In association studies of susceptibility allele and risk of breast cancer, controlling other risk factors such as risk factors related to life style and hormonal play an important role. Many studies reviewed in this systematic review included control for known risk factors; in some studies, the analysis were done based on subgroup analysis and some studies used statistical modeling. Studies included in our analysis control extraneous risk factors either through subgroup analysis (grouping the study subjects into pre and post menopause) or by using multivariable models. Many of the studies were case-control studies some of which were population and clinical based studies. As population based case and controls are less prone to bias, our systematic review identifies many studies whose results can be used for further studies such as met-analysis.
In epidemiology, systematic reviews are done for different purposes. Our systematic review's aim was to identify all studies that assessed the relationship between risk of breast cancer and susceptibility alleles of main base excision repair genes (XRCC1 and OGG1). The systematic approach makes sure that all studies are included and properly evaluated. The fact that our systematic review was able to use major databases (PubMed and Web of Sciences) indicates that we were able to identify all studies indexed in these two databases which cover a large part of English language indexed publications. The inclusion of two databases and manual search of the references of other systematic reviews and meta analyses have lower chances of missing major and important studies indicating high degrees of completeness.
The measure of association was another factor, which may be different among different populations. The difference depends on the frequency and magnitude of other modifying factors effecting and interacting with the BER genes. Our systematic review reveals that, the association between risk of breast cancer and XCRR1 and OGG1 susceptible allele depended on the model of inheritance and different model can show different effects on different population. Further studies are needed to assess the effect(s) of inheritance model on the risk of breast cancer.
Conclusions
Systematic search of major databases identify many studies addressing the relationship between breast cancer and susceptible alleles in the base excision repair genes and the fact that there are many variations in the magnitude of association depending on model of inheritance and the population of the study.
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